Public Company Healthcare

Syneos Health

Morrisville, North Carolina, United States

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. It translates clinical, commercial and real-world insights into outcomes to address modern market realities and speed delivery of important therapies to patients.

Focus Areas
Clinical Development (CRO), Medical Affairs, Commercial Services

Tracked deals

3

3 tracked deals across 2020-2021.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

3 buyout

Syneos Health Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for Syneos Health. 1 2020 2 2021

Supporting Data

Recent Transactions

  • Buyer
    Elligo Health Research, Morgan Stanley Expansion Capital, Ally Bridge Group, Norwest Venture Partners, Cerner, Hatteras Venture Partners, Noro-Moseley Partners, Piper Sandler Merchant Banking, Shumway Capital, Syneos Health
    Target
    ClinEdge, GuideStar Research, BTC of New Bedford
    Type
    Buyout

    Elligo Health Research completed the acquisition of ClinEdge (including GuideStar Research and BTC of New Bedford) as part of a $135 million financing led by Morgan Stanley Expansion Capital and Ally Bridge Group, with participation from Norwest Venture Partners and existing investors. The deal expands Elligo’s global scale and capabilities by combining ClinEdge’s research practice management and clinical services with Elligo’s IntElligo technology, EHR-derived data access, and trial-acceleration platform.

  • Buyer
    Syneos Health
    Target
    StudyKIK
    Seller
    Kinderhook Industries, LLC
    Type
    Buyout

    Syneos Health acquired StudyKIK, a technology-enabled patient recruitment and retention company, from Kinderhook Industries. Financial terms were not disclosed; StudyKIK's platform (covering millions of patients and thousands of protocols/sites) will be integrated to expand Syneos' patient-focused, technology-enabled capabilities.

  • Buyer
    Syneos Health
    Target
    Synteract
    Seller
    Amulet Capital Partners
    Type
    Buyout

    Syneos Health (NASDAQ: SYNH) has completed the acquisition of Synteract, a full-service contract research organization (CRO) focused on emerging biopharma. The seller was Amulet Capital Partners, which had previously built Synteract through organic investment and add-on acquisitions.

Related Acquisition Pages

Selling a company? Get in front of buyers like Syneos Health

Turn tracked acquisition activity into an outreach-ready buyer list.